Global Medical Imaging Reagents Market: Emergence of Advanced Technologies and Global Industry Analysis 2019!! Date: 02-27-2017 05:10 PM CET Category: Health & Medicine Press release from: Transparency Market Research - Pharmaceutical
A new Transparency Market Research report states that the global medical imaging reagents market stood at US$10.3 bn in 2012 and is predicted to touch US$18.5 bn by 2019, by rising at an 8.80% CAGR between 2013 and 2019. The title of the report is “Medical Imaging Reagents Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 2019.” Browse the full Medical Imaging Reagents Market (Class: Contrast Reagents, Optical Reagents and Nuclear Reagents; Technology: Nanoparticles, Fluorescent Proteins, Fluorescent Dyes and Probes, Radiopharmaceuticals and Quantum Dots & Application: Diagnostics, Drug Discovery and Development and Research and Development) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019 report at www.transparencymarketresearch.com/biologic-imaging-reage... Medical imaging reagents are compounds that are designed to enhance images obtained through medical imaging devices. These reagents enable doctors to evaluate the nature of a tumor i.e. whether it is malignant or benign in nature. They also help in detecting cancerous spots within the human body. Hence, these reagents play a major role in pharmaceuticals, diagnostics, life sciences and medical industries, and biotechnology. Medical imaging reagents are typically employed in animal research before their use in human medical studies. As per the report, the rising geriatric population and the rising occurrence of cancer, neurological, and cardiovascular diseases are predicted to fuel the market for medical imaging reagents. In addition¸ the soaring demand for diagnostic imaging procedures and the rising number of technological advancements globally will also augment the development of the market. Furthermore, the strengthening of distribution channels within developing markets and the proliferation of nuclear-product-based personalized therapy are the key opportunities seen in the market. On the other hand, the strict regulatory approvals and the dearth of imaging reagent suppliers may inhibit the growth of the market for medical imaging reagents. In addition, consumers’ hesitation toward adopting nuclear products may also impede the growth of the market in the coming years.
Seite 1 / 3